Skip to content
Disclosery

VHCP Management, LLC

Follow

13F filer, CIK 1479355, NEW YORK, NY

VHCP Management, LLC reported $92,999,000 across 21 holdings for the quarter ended 2016-12-31, in a 13F-HR filed 2017-02-13. Its ten largest share positions make up 87.33% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-17-001784

Period
2016-12-31
Reported value
$93M
Holdings
21
Top 10 weight
87.33%
New
1
Sold out
4

Largest buys vs the previous quarter

SecurityShares changeApprox. value
RA PHARMACEUTICALS INCnew+232,500$3.53M
BCRXadded+150,000$950K
OCERA THERAPEUTICS INC COMadded+55,500$117K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ZAFGEN INCexited-602,114-$1.99M
ONCexited-51,000-$1.57M
ACHILLION PHARMACEUTICALS INexited-180,000-$1.46M
RGNXexited-24,089-$337K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2016

Share positions as resolved from 13F-HR 0000950123-17-001784, largest first. % of portfolio is the value over $92,999,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
DBV TechnologiesDBV TechnologiesQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: 693,810 shares; 2015Q2: 693,810 shares; 2015Q3: 693,810 shares; 2015Q4: 463,643 shares; 2016Q1: 456,893 shares; 2016Q2: 456,893 shares; 2016Q3: 456,893 shares; 2016Q4: 456,893 shares 456,893$31.1M33.47%0
HRTXHERON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: 1,095,734 shares; 2015Q2: 1,095,734 shares; 2015Q3: 1,095,734 shares; 2015Q4: 1,095,734 shares; 2016Q1: 1,095,734 shares; 2016Q2: 1,095,734 shares; 2016Q3: 1,095,734 shares; 2016Q4: 1,095,734 shares 1,095,734$14.4M15.43%0Timeline
CHRSCOHERUS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: 870,269 shares; 2015Q2: 870,269 shares; 2015Q3: 870,269 shares; 2015Q4: 611,010 shares; 2016Q1: 611,010 shares; 2016Q2: 611,010 shares; 2016Q3: 305,505 shares; 2016Q4: 305,505 shares 305,505$8.6M9.25%0Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: 1,744,356 shares; 2015Q2: 373,686 shares; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: 562,943 shares; 2016Q2: 1,005,104 shares; 2016Q3: 1,005,104 shares; 2016Q4: 1,155,104 shares 1,155,104$7.31M7.86%+150,000Timeline
FLAMEL TECHNOLOGIES-SP ADRFLAMEL TECHNOLOGIES-SP ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: 500,000 shares; 2015Q2: 500,000 shares; 2015Q3: 500,000 shares; 2015Q4: 500,000 shares; 2016Q1: 500,000 shares; 2016Q2: 500,000 shares; 2016Q3: 500,000 shares; 2016Q4: 500,000 shares 500,000$5.2M5.59%0
RA PHARMACEUTICALS INCRA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: not reported; 2016Q2: not reported; 2016Q3: not reported; 2016Q4: 232,500 shares 232,500$3.53M3.8%new
Adverum Biotechnologies, In…Adverum Biotechnologies, Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: not reported; 2016Q2: 1,102,735 shares; 2016Q3: 1,102,735 shares; 2016Q4: 1,102,735 shares 1,102,735$3.2M3.44%0
LIPOCINE INC NEWLIPOCINE INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: 669,921 shares; 2015Q2: 1,269,921 shares; 2015Q3: 1,269,921 shares; 2015Q4: 849,921 shares; 2016Q1: 849,921 shares; 2016Q2: 849,921 shares; 2016Q3: 849,921 shares; 2016Q4: 849,921 shares 849,921$3.13M3.36%0
COLUCID PHARMACEUTICALS INCCOLUCID PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: not reported; 2016Q2: not reported; 2016Q3: 68,190 shares; 2016Q4: 68,190 shares 68,190$2.48M2.67%0
AXOVANT SCIENCES LTDAXOVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: 184,110 shares; 2016Q2: 184,110 shares; 2016Q3: 184,110 shares; 2016Q4: 184,110 shares 184,110$2.29M2.46%0
OCERA THERAPEUTICS INC COMOCERA THERAPEUTICS INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: 703,730 shares; 2015Q2: 703,730 shares; 2015Q3: 703,730 shares; 2015Q4: 703,730 shares; 2016Q1: 796,550 shares; 2016Q2: 796,550 shares; 2016Q3: 856,550 shares; 2016Q4: 912,050 shares 912,050$1.92M2.06%+55,500
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: 811,152 shares; 2015Q2: 811,152 shares; 2015Q3: 811,152 shares; 2015Q4: 90,000 shares; 2016Q1: 90,000 shares; 2016Q2: 90,000 shares; 2016Q3: 90,000 shares; 2016Q4: 90,000 shares 90,000$1.82M1.96%0Timeline
EDGE THERAPEUTICS INCEDGE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: 135,000 shares; 2016Q1: 135,000 shares; 2016Q2: 135,000 shares; 2016Q3: 135,000 shares; 2016Q4: 135,000 shares 135,000$1.69M1.82%0
STEMLINE THERAPEUTICS INCSTEMLINE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: 451,400 shares; 2015Q2: 451,400 shares; 2015Q3: 451,400 shares; 2015Q4: 135,420 shares; 2016Q1: 135,420 shares; 2016Q2: 135,420 shares; 2016Q3: 135,420 shares; 2016Q4: 135,420 shares 135,420$1.45M1.56%0
Alcobra LtdAlcobra LtdQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: 1,500,000 shares; 2015Q2: 1,500,000 shares; 2015Q3: 1,500,000 shares; 2015Q4: 484,500 shares; 2016Q1: 484,500 shares; 2016Q2: 623,313 shares; 2016Q3: 658,910 shares; 2016Q4: 658,910 shares 658,910$1.38M1.49%0
ARCA biopharma IncARCA biopharma IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: not reported; 2015Q2: 10,789,324 shares; 2015Q3: 1,541,331 shares; 2015Q4: 462,399 shares; 2016Q1: 462,399 shares; 2016Q2: 462,399 shares; 2016Q3: 462,399 shares; 2016Q4: 462,399 shares 462,399$1.32M1.42%0
AKARI THERAPEUTICS PLCAKARI THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: 527,842 shares; 2015Q4: 158,352 shares; 2016Q1: 158,352 shares; 2016Q2: 158,352 shares; 2016Q3: 158,352 shares; 2016Q4: 158,352 shares 158,352$1.11M1.2%0
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: 75,000 shares; 2016Q1: 64,200 shares; 2016Q2: 64,200 shares; 2016Q3: 64,200 shares; 2016Q4: 64,200 shares 64,200$706K0.76%0Timeline
AUDENTES THERAPEUTICS INC.AUDENTES THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: not reported; 2016Q2: not reported; 2016Q3: 15,000 shares; 2016Q4: 15,000 shares 15,000$274K0.29%0
Sierra Oncology, Inc.Sierra Oncology, Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: 250,000 shares; 2015Q4: 75,000 shares; 2016Q1: 56,056 shares; 2016Q2: 56,056 shares; 2016Q3: 56,056 shares; 2016Q4: 56,056 shares 56,056$84K0.09%0
AEGLEA BIOTHERAPEUTICS INCAEGLEA BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: not reported; 2016Q2: 6,000 shares; 2016Q3: 6,000 shares; 2016Q4: 6,000 shares 6,000$26K0.03%0

Sold out in Q4 2016

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ZAFGEN INCZAFGEN INC602,114$1.99Mshares
ONCBEONE MEDICINES LTD51,000$1.57Mshares
ACHILLION PHARMACEUTICALS INACHILLION PHARMACEUTICALS IN180,000$1.46Mshares
RGNXREGENXBIO INC24,089$337Kshares

How Q4 2016 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-17-001784 base2017-02-13acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0000950123-17-001784 Quarter ended 2016-12-312017-02-13acceptance time not in the bulk data set
13F-HR 0000950123-16-022473 Quarter ended 2016-09-302016-11-14acceptance time not in the bulk data set
13F-HR 0000950123-16-019779 Quarter ended 2016-06-302016-08-12acceptance time not in the bulk data set
13F-HR 0000950123-16-017146 Quarter ended 2016-03-312016-05-13acceptance time not in the bulk data set
13F-HR 0000950123-16-014511 Quarter ended 2015-12-312016-02-12acceptance time not in the bulk data set
13F-HR 0000950123-15-011918 Quarter ended 2015-09-302015-11-13acceptance time not in the bulk data set
13F-HR 0000950123-15-008947 Quarter ended 2015-06-302015-08-13acceptance time not in the bulk data set
13F-HR 0000950123-15-006018 Quarter ended 2015-03-312015-05-14acceptance time not in the bulk data set
13F-HR 0000950123-15-002068 Quarter ended 2014-12-312015-02-13acceptance time not in the bulk data set
13F-HR 0000950123-14-011751 Quarter ended 2014-09-302014-11-13acceptance time not in the bulk data set
13F-HR 0000950123-14-008686 Quarter ended 2014-06-302014-08-13acceptance time not in the bulk data set
13F-HR 0000950123-14-005976 Quarter ended 2014-03-312014-05-14acceptance time not in the bulk data set
13F-HR 0000950123-14-002167 Quarter ended 2013-12-312014-02-13acceptance time not in the bulk data set
13F-HR 0000950123-13-009925 Quarter ended 2013-09-302013-11-15acceptance time not in the bulk data set
13F-HR 0000950123-13-006842 Quarter ended 2013-06-302013-08-14acceptance time not in the bulk data set